Mds Podcast

What's new in the pathophysiology of Parkinson's disease? • 2024 MDS Congress

Informações:

Synopsis

Alpha-synuclein based biomarkers have dominated the Parksinon's disease field over the past few years. Dr. Andrew Siderowf shares his views on the future of these biomarkers and what else the field may have in store.